MedTrace Logo

DIAMOND AF Post-Approval Study

NCT05230524 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2026-04-07

No results posted yet for this study

Summary

The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

DiamondTemp™ Ablation System

Pulmonary vein isolation will be performed with the DiamondTemp™ Ablation System

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Principal Investigators

  • Khaldoun Tarakji, MD · Medtronic CAS Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2025-12-17
Completion
2025-12-17
FDA Device
Yes

Countries

  • United States
  • France
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05230524 on ClinicalTrials.gov